Transformative Cystic Fibrosis Treatment Offers Hope to Ukrainian Patients

Sionna selects which cystic fibrosis drug it will study in a mid-stage test

Newly-public biotech Sionna Therapeutics is ready to head into mid-stage testing. In an update reporting healthy volunteer data for two cystic fibrosis drugs, Sionna said it will move SION-719 into a Phase ...

Transformative Cystic Fibrosis Treatment Offers Hope to Ukrainian Patients

UKRAINE – A good day for Yaroslava Koshel — one of hundreds of Ukrainians living with cystic fibrosis, or CF — might include a walk in the park or exploring a new corner of her adopted hometown, Lviv. It might mean time with her mother unclouded by illness, quiet hours spent painting or imagining a future she once thought out of reach. CF is a genetic disease that damages the lungs, digestive system, and other organs. Until the development in 20…